Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hyperpnea and Hyperventilation01:25

Hyperpnea and Hyperventilation

3.8K
Hyperventilation refers to a higher-than-normal rate and depth of breathing, often associated with anxiety attacks. This excessive breathing surpasses the body's need to expel CO2, leading to a condition known as hypocapnia - an unusually low level of carbon dioxide in the blood. Hypocapnia can constrict cerebral blood vessels, reducing blood flow to the brain, which may result in dizziness or fainting. Early signs include tingling and muscle spasms in the hands and face, caused by falling...
3.8K
Factors Affecting Respiration01:24

Factors Affecting Respiration

10.3K
Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process:
10.3K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

1.5K
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

1.1K
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
1.1K
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

843
Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
843
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

706
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
706

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammation and vascular diseases.

Vnitrni lekarstvi·2022
Same author

Are proton pump inhibitors an effective and safe drug not only in the prophylaxis of gastrointestinal bleeding in antithrombotic treatment?

Vnitrni lekarstvi·2020
Same author

Diosmin/hesperidin: a cooperating tandem, or is diosmin crucial and hesperidin an inactive ingredient only?

Vnitrni lekarstvi·2020
Same author

Anticoagulant therapy in the elderly.

Vnitrni lekarstvi·2019
Same author

[Anticoagulant therapy in secondary prevention of coronary events].

Vnitrni lekarstvi·2015
Same author

[Extended options of anticoagulant treatment in thromboembolism].

Vnitrni lekarstvi·2015

Related Experiment Video

Updated: Mar 27, 2026

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
14:09

Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

Published on: March 21, 2013

22.1K

[Mountain sickness].

Jan Bultas

    Casopis Lekaru Ceskych
    |January 12, 2016
    PubMed
    Summary

    Mountain sickness, a risk of mountaineering, ranges from mild symptoms to life-threatening edema. Treatment focuses on restoring oxygen levels, with medications offering supportive care.

    Area of Science:

    • Altitude sickness
    • Physiology
    • Pharmacology

    Background:

    • Mountaineering presents significant health risks, notably mountain sickness.
    • Acute mountain sickness involves subjective symptoms like headache and nausea.
    • Severe forms include life-threatening cerebral or pulmonary edema due to hypoxemia.

    Purpose of the Study:

    • To outline the pathophysiology of acute and chronic mountain sickness.
    • To discuss the causal and supportive therapeutic interventions.
    • To review prophylactic pharmacotherapies for altitude-related illnesses.

    Main Methods:

    • Review of existing literature on mountain sickness.
    • Analysis of physiological mechanisms underlying altitude-related diseases.
    • Compilation of pharmacological treatments and their mechanisms.
    Keywords:
    acute mountain sickness - high-altitude pulmonary edema - high-altitude cerebral edema - pathophysiology - clinical picture - treatment.

    More Related Videos

    Quantitative Autonomic Testing
    11:40

    Quantitative Autonomic Testing

    Published on: July 19, 2011

    59.1K

    Related Experiment Videos

    Last Updated: Mar 27, 2026

    Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance
    14:09

    Tilt Testing with Combined Lower Body Negative Pressure: a "Gold Standard" for Measuring Orthostatic Tolerance

    Published on: March 21, 2013

    22.1K
    Quantitative Autonomic Testing
    11:40

    Quantitative Autonomic Testing

    Published on: July 19, 2011

    59.1K

    Main Results:

    • Acute mountain sickness stems from low oxygen tension causing hypoxemia and ischemia.
    • Chronic forms involve maladaptive processes like pulmonary hypertension and polycythemia.
    • Pharmacological prophylaxis includes acetazolamide, dexamethasone, salmeterol, calcium channel blockers, and PDE-5 inhibitors.

    Conclusions:

    • The primary treatment for mountain sickness is restoring adequate oxygen tension.
    • Pharmacotherapy plays a supportive role in managing symptoms and preventing severe forms.
    • Prophylaxis involves medications targeting respiratory stimulation, edema reduction, lymphatic drainage, and pulmonary hypertension.